Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 10 (of 10 Records)

Query Trace: Neoplasms and SLC22A16[original query]
Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients.
Pharmacogenomics 2007 Jun 8 (6): 567-75.
Lal Suman, Wong Zee Wan, Jada Srinivasa Rao, Xiang Xiaoqiang, Chen Shu Xiao, Ang Peter Cher Siang, Figg William D, Lee Edmund Jd, Chowbay Balr
Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.
British journal of cancer 2010 Mar 102 (6): 1003-9.
Bray J, Sludden J, Griffin M J, Cole M, Verrill M, Jamieson D, Boddy A
Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients.
British journal of clinical pharmacology 2013 Jun 75 (6): 1497-505.
Voon Pei Jye, Yap Hui Ling, Ma Cho-Yee-Thu, Lu Fan, Wong Andrea L A, Sapari Nur Sabrina, Soong Richie, Soh Thomas I P, Goh Boon-Cher, Lee How-Sung, Lee Soo-Ch
Generalized Multifactor Dimensionality Reduction (GMDR) Analysis of Drug-Metabolizing Enzyme-Encoding Gene Polymorphisms may Predict Treatment Outcomes in Indian Breast Cancer Patients.
World journal of surgery 2015 Oct .
Agarwal Gaurav, Tulsyan Sonam, Lal Punita, Mittal Balr
Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.
Oncotarget 2016 Oct 7 (41): 66790-66808.
Tecza Karolina, Pamula-Pilat Jolanta, Lanuszewska Joanna, Grzybowska E
Association of ABCB1 and SLC22A16 Gene Polymorphisms with Incidence of Doxorubicin-Induced Febrile Neutropenia: A Survey of Iranian Breast Cancer Patients.
PloS one 2016 12 11 (12): e0168519.
Faraji Abolfazl, Dehghan Manshadi Hamid Reza, Mobaraki Maryam, Zare Mahkameh, Houshmand Masso
Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.
Oncotarget 2018 Feb 9 (10): 9114-9136.
Tecza Karolina, Pamula-Pilat Jolanta, Lanuszewska Joanna, Butkiewicz Dorota, Grzybowska E
Variants of SLC22A16 Predict the Efficacy of Platinum Combination Chemotherapy in Advanced Non-small-cell Lung Cancer.
Anticancer research 2020 Aug 40 (8): 4245-4251.
Takeuchi Akira, Oguri Tetsuya, Fukuda Satoshi, Sone Kazuki, Kagawa Yusuke, Uemura Takehiro, Takakuwa Osamu, Maeno Ken, Fukumitsu Kensuke, Kanemitsu Yoshihiro, Tajiri Tomoko, Ohkubo Hirotsugu, Takemura Masaya, Ito Yutaka, Niimi Ak
Genetic 3'UTR variations and clinical factors significantly contribute to survival prediction and clinical response in breast cancer patients.
Scientific reports 2020 Mar 10 (1): 5736.
Pamu?a-Pi?at Jolanta, T?cza Karolina, Kalinowska-Herok Magdalena, Grzybowska E
Association between the genetic polymorphisms of the pharmacokinetics of anthracycline drug and myelosuppression in a patient with breast cancer with anthracycline-based chemotherapy.
Life sciences 2021 3 276 119392.
Cui Lulu, Huang Jia, Zhan Yongtao, Qiu Ni, Jin Huan, Li Jia, Huang Huiqi, Li Hongshe
TOP